Inhibition of ALAS1 activity exerts anti-tumour effects on colorectal cancer in vitro

Conclusions: The abnormal expression of ALAS1 is closely related to the proliferation and metastasis of CRC cells, suggesting that ALAS1 may be a novel therapeutic target for the treatment of CRC.

Source: The Saudi Journal of Gastroenterology - May 26, 2020 Category: Gastroenterology Authors: Yalei Zhao Xiaoyun Zhang Yabin Liu Yiping Ma Pong Kong Tianliang Bai Mei Han Binghui Li Source Type: research